Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hunter

Showing results (1191-1200 of 1,215) with videos related to

Pageof 122
Sort By:
Plos One|June 2, 2022
Cost-utility analysis of adding abiraterone acetate plus prednisone/prednisolone to long-term hormone therapy in newly diagnosed advanced prostate cancer in England: Lifetime decision model based on STAMPEDE trial dataCaroline S Clarke, Rachael M Hunter, Andrea Gabrio, et al.
Journal of Medical Genetics|November 19, 2008
Detection of cryptic pathogenic copy number variations and constitutional loss of heterozygosity using high resolution SNP microarray analysis in 117 patients referred for cytogenetic analysis and impact on clinical practiceD L Bruno, D Ganesamoorthy, J Schoumans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2025
Glofitamab Combined With Pola-R-CHP or R-CHOP as First Therapy in Younger Patients With High-Risk Large B-Cell Lymphoma: Results From the COALITION StudyAdrian Minson, Emma Verner, Pratyush Giri, et al.
Bioorganic & Medicinal Chemistry Letters|August 24, 2010
Discovery of 8-azabicyclo[3.2.1]octan-3-yloxy-benzamides as selective antagonists of the kappa opioid receptor. Part 1Todd A Brugel, Reed W Smith, Michael Balestra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 16, 2014
Genomic classification of serous ovarian cancer with adjacent borderline differentiates RAS pathway and TP53-mutant tumors and identifies NRAS as an oncogenic driverCatherine Emmanuel, Yoke-Eng Chiew, Joshy George, et al.
Human Molecular Genetics|April 18, 1998
Transmission of haplotypes of microsatellite markers rather than single marker alleles in the mapping of a putative type 1 diabetes susceptibility gene (IDDM6)T R Merriman, I A Eaves, R C Twells, et al.
Blood|October 26, 2021
Asxl1 loss cooperates with oncogenic Nras in mice to reprogram the immune microenvironment and drive leukemic transformationXiaona You, Fabao Liu, Moritz Binder, et al.
American Journal of Respiratory and Critical Care Medicine|February 11, 2022
Sleep-disordered Breathing in Pregnancy and after Delivery: Associations with Cardiometabolic HealthFrancesca L Facco, Susan Redline, Shannon M Hunter, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 28, 2018
Mycobacterium chimaera infection following cardiac surgery in the United Kingdom: clinical features and outcome of the first 30 casesJ E Scriven, A Scobie, N Q Verlander, et al.
BMC Genetics|February 22, 2005
Construction and analysis of tag single nucleotide polymorphism maps for six human-mouse orthologous candidate genes in type 1 diabetesLisa M Maier, Deborah J Smyth, Adrian Vella, et al.
Pageof 122

Showing results (1191-1200 of 1,215) with videos related to

Sort By:
Pageof 122
Plos One|June 2, 2022
Cost-utility analysis of adding abiraterone acetate plus prednisone/prednisolone to long-term hormone therapy in newly diagnosed advanced prostate cancer in England: Lifetime decision model based on STAMPEDE trial dataCaroline S Clarke, Rachael M Hunter, Andrea Gabrio, et al.
Journal of Medical Genetics|November 19, 2008
Detection of cryptic pathogenic copy number variations and constitutional loss of heterozygosity using high resolution SNP microarray analysis in 117 patients referred for cytogenetic analysis and impact on clinical practiceD L Bruno, D Ganesamoorthy, J Schoumans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2025
Glofitamab Combined With Pola-R-CHP or R-CHOP as First Therapy in Younger Patients With High-Risk Large B-Cell Lymphoma: Results From the COALITION StudyAdrian Minson, Emma Verner, Pratyush Giri, et al.
Bioorganic & Medicinal Chemistry Letters|August 24, 2010
Discovery of 8-azabicyclo[3.2.1]octan-3-yloxy-benzamides as selective antagonists of the kappa opioid receptor. Part 1Todd A Brugel, Reed W Smith, Michael Balestra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 16, 2014
Genomic classification of serous ovarian cancer with adjacent borderline differentiates RAS pathway and TP53-mutant tumors and identifies NRAS as an oncogenic driverCatherine Emmanuel, Yoke-Eng Chiew, Joshy George, et al.
Human Molecular Genetics|April 18, 1998
Transmission of haplotypes of microsatellite markers rather than single marker alleles in the mapping of a putative type 1 diabetes susceptibility gene (IDDM6)T R Merriman, I A Eaves, R C Twells, et al.
Blood|October 26, 2021
Asxl1 loss cooperates with oncogenic Nras in mice to reprogram the immune microenvironment and drive leukemic transformationXiaona You, Fabao Liu, Moritz Binder, et al.
American Journal of Respiratory and Critical Care Medicine|February 11, 2022
Sleep-disordered Breathing in Pregnancy and after Delivery: Associations with Cardiometabolic HealthFrancesca L Facco, Susan Redline, Shannon M Hunter, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 28, 2018
Mycobacterium chimaera infection following cardiac surgery in the United Kingdom: clinical features and outcome of the first 30 casesJ E Scriven, A Scobie, N Q Verlander, et al.
BMC Genetics|February 22, 2005
Construction and analysis of tag single nucleotide polymorphism maps for six human-mouse orthologous candidate genes in type 1 diabetesLisa M Maier, Deborah J Smyth, Adrian Vella, et al.
Pageof 122